A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL

Enrollment

507

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2006

Conditions

METABOLIC SYNDROMEHYPERTENSIONPRE-HYPERTENSION

Interventions

DRUG

valsartan plus hydrochlorothiazide

Trial Locations (1)

Novartis Pharmaceuticals, East Hanover